Ключевые слова
Как цитировать
Аннотация
Цель данного обзора — обобщить результаты исследований отношения пациентов к скринингу онкологических заболеваний. В рамках обзора были изучены полные тексты 63 публикаций по четырём распространённым онкологическим заболеваниям: рак молочной железы, рак шейки матки, колоректальный рак и рак лёгкого. Для каждого заболевания отмечены особенности отношения пациентов к скрининговым мероприятиям, которые выражаются в их готовности проходить обследования, в их осведомлённости о заболевании и скрининге на него, в мотиваторах и барьерах на пути к принятию участия в онкоскрининге. Для всех заболеваний найдена распространённая поддержка скрининговых мероприятий среди различных групп населения, но ставится под сомнение осознанность этой поддержки. Обзор завершается рекомендациями по проведению исследований отношения пациентов к скринингу онкологических заболеваний в России.
Библиографические ссылки
World Health Organization Regional Office for Europe. A short guide to cancer screening. Increase effectiveness, maximize benefits and minimize harm [Internet]. Copenhagen: WHO Regional Office for Europe. 2022;45. Available from: https://apps.who.int/iris/bitstream/handle/10665/351396/9789289057561-eng.pdf.
Cullati S, Charvet-Bérard AI, Perneger TV. Cancer screening in a middle-aged general population: factors associated with practices and attitudes. BMC Public Health. 2009;9:118. https://doi.org/10.1186/1471-2458-9-118.
Wools A, Dapper EA, Leeuw JRJD. Colorectal cancer screening participation: a systematic review. Eur J Public Health. 2016;26(1):158-68. https://doi.org/10.1093/eurpub/ckv148.
Kolahdooz F, Jang SL, Corriveau A, et al. Knowledge, attitudes, and behaviours towards cancer screening in indigenous populations: a systematic review. Lancet Oncol. 2014;15(11):e504-16. https://doi.org/10.1016/S1470-2045(14)70508-X.
Smith J, Dodd RH, Gainey KM, et al. Patient-Reported Factors Associated With Older Adults’ Cancer Screening Decision-making: A Systematic Review. JAMA Netw Open. 2021;4(11):e2133406. https://doi.org/10.1001/jamanetworkopen.2021.33406.
Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209-49. https://doi.org/10.3322/caac.21660.
Harbeck N, Penault-Llorca F, Cortes J, et al. Breast cancer. Nat Rev Dis Primer. 2019;5(1):66. https://doi.org/10.1038/s41572-019-0111-2.
Sechopoulos I, Mann RM. Stand-alone artificial intelligence - The future of breast cancer screening? The Breast. 2020;49:254-60. https://doi.org/10.1016/j.breast.2019.12.014.
Freeman K, Geppert J, Stinton C, et al. Use of artificial intelligence for image analysis in breast cancer screening programmes: systematic review of test accuracy. BMJ. 2021;374:1872. https://doi.org/10.1136/bmj.n1872.
Torres-Mejía G, Smith RA, Carranza-Flores MDLL, et al. Radiographers supporting radiologists in the interpretation of screening mammography: a viable strategy to meet the shortage in the number of radiologists. BMC Cancer. 2015;15(1):410. https://doi.org/10.1186/s12885-015-1399-2.
European Commission Initiatives on Breast and Colorectal Cancer. Inviting and informing women about screening [Internet]. 2023. Available from: https://healthcare-quality.jrc.ec.europa.eu/european-breast-cancer-guidelines/Invitation-to-screening-and-decision-aid.
Wegwarth O, Widschwendter M, Cibula D, et al. What do European women know about their female cancer risks and cancer screening? A cross-sectional online intervention survey in five European countries. BMJ Open. 2018;8(12):e023789. https://doi.org/10.1136/bmjopen-2018-023789.
Mascara M, Constantinou C. Global perceptions of women on breast cancer and barriers to screening. Curr Oncol Rep. 2021;23(7):74. https://doi.org/10.1007/s11912-021-01069-z.
Seaman K, Dzidic PL, Castell E, et al. A systematic review of women’s knowledge of screening mammography. The Breast. 2018;42:81-93. https://doi.org/10.1016/j.breast.2018.08.102.
Noman S, Shahar HK, Abdul Rahman H, et al. The Effectiveness of Educational Interventions on Breast Cancer Screening Uptake, Knowledge, and Beliefs among Women: A Systematic Review. Int J Environ Res Public Health. 2020;18(1):263. https://doi.org/10.3390/ijerph18010263.
Satoh M, Sato N. Relationship of attitudes toward uncertainty and preventive health behaviors with breast cancer screening participation. BMC Womens Health. 2021;21(1):171. https://doi.org/10.1186/s12905-021-01317-1.
Ritchie D, Van Hal G, Van Den Broucke S. Factors affecting intention to screen after being informed of benefits and harms of breast cancer screening: a study in 5 European countries in 2021. Arch Public Health. 2022;80(1):143. https://doi.org/10.1186/s13690-022-00902-6.
Özkan İ, Taylan S. Barriers to women’s breast cancer screening behaviors in several countries: A meta-synthesis study. Health Care Women Int. 2021;42(7-9):1013-43. https://doi.org/10.1080/07399332.2020.1814777.
Zha N, Alabousi M, Patel BK, et al. Beyond universal health care: barriers to breast cancer screening participation in Canada. J Am Coll Radiol. 2019;16(4):570-9. https://doi.org/10.1016/j.jacr.2019.02.044.
Lennox-Chhugani N, Chen Y, Pearson V, et al. Women’s attitudes to the use of AI image readers: a case study from a national breast screening programme. BMJ Health Care Inform. 2021;28(1):e100293. https://doi.org/10.1136/bmjhci-2020-100293.
Pesapane F, Rotili A, Valconi E, et al. Women’s perceptions and attitudes to the use of AI in breast cancer screening: a survey in a cancer referral centre. Br J Radiol. 2023;96(1141):20220569. https://doi.org/10.1259/bjr.20220569.
Ongena YP, Yakar D, Haan M, et al. Artificial Intelligence in Screening Mammography: A Population Survey of Women’s Preferences. J Am Coll Radiol. 2021;18(1):79-86. https://doi.org/10.1016/j.jacr.2020.09.042.
Steenbergen RDM, Snijders PJF, Heideman DAM, et al. Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions. Nat Rev Cancer. 2014;14(6):395-405. https://doi.org/10.1038/nrc3728.
World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem [Internet]. Gevena: World Health Organization. 2020;52. Available from: https://www.who.int/publications/i/item/9789240014107.
World Health Organization. WHO Cervical Cancer Elimination Initiative: from call to action to global movement [Internet]. World Health Organization. 2023;14. Available from: https://www.who.int/publications/m/item/who-cervical-cancer-elimination-initiative--from-call-to-action-to-global-movement.
Bruni L, Serrano B, Roura E, et al. Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis. Lancet Glob Health. 2022;10(8):e1115-27. https://doi.org/10.1016/S2214-109X(22)00241-8.
Abu SH, Woldehanna BT, Nida ET, et al. The role of health education on cervical cancer screening uptake at selected health centers in Addis Ababa. Robboy SJ, ed. PLOS ONE. 2020;15(10):e0239580. https://doi.org/10.1371/journal.pone.0239580.
Devarapalli P, Labani S, Nagarjuna N, et al. Barriers affecting uptake of cervical cancer screening in low and middle income countries: A systematic review. Indian J Cancer. 2018;55(4):318. https://doi.org/10.4103/ijc.IJC_253_18.
Akinlotan M, Bolin JN, Helduser J, et al. Cervical cancer screening barriers and risk factor knowledge among uninsured women. J Community Health. 2017;42(4):770-8. https://doi.org/10.1007/s10900-017-0316-9.
Shin HY, Song SY, Jun JK, et al. Barriers and strategies for cervical cancer screening: What do female university students know and want? PLOS ONE. 2021;16(10):e0257529. https://doi.org/10.1371/journal.pone.0257529.
Peterson CE, Silva A, Goben AH, et al. Stigma and cervical cancer prevention: A scoping review of the U.S. literature. Prev Med. 2021;153:106849. https://doi.org/10.1016/j.ypmed.2021.106849.
Hamdiui N, Marchena E, Stein ML, et al. Decision-making, barriers, and facilitators regarding cervical cancer screening participation among Turkish and Moroccan women in the Netherlands: a focus group study. Ethn Health. 2022;27(5):1147-65. https://doi.org/10.1080/13557858.2020.1863921.
US Preventive Services Task Force, Davidson KW, Barry MJ, et al. Screening for colorectal cancer: US preventive services task force recommendation statement. JAMA. 2021;325(19):1965. https://doi.org/10.1001/jama.2021.6238.
Ely JW, Levy BT, Daly J, et al. Patient beliefs about colon cancer screening. J Cancer Educ. 2016;31(1):39-46. https://doi.org/10.1007/s13187-015-0792-5.
Jimbo M, Sen A, Plegue MA, et al. Correlates of patient intent and preference on colorectal cancer screening. Am J Prev Med. 2017;52(4):443-50. https://doi.org/10.1016/j.amepre.2016.11.026.
Honein-AbouHaidar GN, Kastner M, Vuong V, et al. Systematic review and meta-study synthesis of qualitative studies evaluating facilitators and barriers to participation in colorectal cancer screening. Cancer Epidemiol Biomarkers Prev. 2016;25(6):907-17. https://doi.org/10.1158/1055-9965.EPI-15-0990.
Earl V, Beasley D, Ye C, et al. Barriers and facilitators to colorectal cancer screening in african-american men. Dig Dis Sci. 2022;67(2):463-72. https://doi.org/10.1007/s10620-021-06960-0.
Douma LN, Uiters E, Timmermans DRM. Why are the public so positive about colorectal cancer screening? BMC Public Health. 2018;18(1):1212. https://doi.org/10.1186/s12889-018-6106-1.
Hatamian S, Hadavandsiri F, Momenimovahed Z, et al. Barriers and facilitators of colorectal cancer screening in Asia. Ecancermedicalscience. 2021;15. https://doi.org/10.3332/ecancer.2021.1285.
Al Abdouli L, Dalmook H, Akram Abdo M, et al. Colorectal cancer risk awareness and screening uptake among adults in the United Arab Emirates. Asian Pac J Cancer Prev. 2018;19(8). https://doi.org/10.22034/APJCP.2018.19.8.2343.
Wang H, Roy S, Kim J, et al. Barriers of colorectal cancer screening in rural USA: a systematic review. Rural Remote Health. 2019;19(3):5181. https://doi.org/10.22605/RRH5181.
Osborne J, Flight I, Wilson C, et al. The impact of sample type and procedural attributes on relative acceptability of different colorectal cancer screening regimens. Patient Prefer Adherence. 2018;12:1825-36. https://doi.org/10.2147/PPA.S172143.
Almadi M, Alghamdi F. The gap between knowledge and undergoing colorectal cancer screening using the Health Belief Model: A national survey. Saudi J Gastroenterol. 2019;25(1):27-39. https://doi.org/10.4103/sjg.SJG_455_18.
Denizard-Thompson NM, Miller DP, Snavely AC, et al. Effect of a digital health intervention on decreasing barriers and increasing facilitators for colorectal cancer screening in vulnerable patients. Cancer Epidemiol Biomarkers Prev. 2020;29(8):1564-9. https://doi.org/10.1158/1055-9965.EPI-19-1199.
Roberts H, Walker-Dilks C, Sivjee K, et al. Screening high-risk populations for lung cancer: guideline recommendations. J Thorac Oncol. 2013;8(10):1232-7. https://doi.org/10.1097/JTO.0b013e31829fd3d5.
US Preventive Services Task Force, Krist AH, Davidson KW, et al. Screening for lung cancer: US Preventive Services Task Force recommendation statement. JAMA. 2021;325(10):962-70. https://doi.org/10.1001/jama.2021.1117.
Lung Cancer Initiative. Prevention and Early Detection [Internet]. 2017 [cited 2023 Jul 8]. Available from: https://lungcancerinitiative.org/prevention.
Ali N, Lifford KJ, Carter B, et al. Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial. BMJ Open. 2015;5(7):e008254. https://doi.org/10.1136/bmjopen-2015-008254.
Quaife SL, Marlow LAV, McEwen A, et al. Attitudes towards lung cancer screening in socioeconomically deprived and heavy smoking communities: informing screening communication. Health Expect. 2017;20(4):563-73. https://doi.org/10.1111/hex.12481.
Duong DK, Shariff-Marco S, Cheng I, et al. Patient and primary care provider attitudes and adherence towards lung cancer screening at an academic medical center. Prev Med Rep. 2017;6:17-22. https://doi.org/10.1016/j.pmedr.2017.01.012.
Smits SE, McCutchan GM, Hanson JA, et al. Attitudes towards lung cancer screening in a population sample. Health Expect. 2018;21(6):1150=8. https://doi.org/10.1111/hex.12819.
Ahmed F. Thematic analysis of smokers’ attitudes towards lung cancer screening using spiral CT scanning. Research Square [Preprint]. 2022. https://doi.org/10.21203/rs.3.rs-1725186/v1.
Jonnalagadda S, Bergamo C, Lin JJ, et al. Beliefs and attitudes about lung cancer screening among smokers. Lung Cancer. 2012;77(3):526-31. https://doi.org/10.1016/j.lungcan.2012.05.095.
Mishra SI, Sussman AL, Murrietta AM, et al. Patient Perspectives on Low-Dose Computed Tomography for Lung Cancer Screening, New Mexico, 2014. Prev Chronic Dis. 2016;13:160093. https://doi.org/10.5888/pcd13.160093.
Cam NB, Lee YY, Yoon H, et al. Intentions to Undergo Lung Cancer Screening among Korean Men. Asian Pac J Cancer Prev. 2015;16(15):6293-8. https://doi.org/10.7314/apjcp.2015.16.15.6293.
Delmerico J, Hyland A, Celestino P, et al. Patient willingness and barriers to receiving a CT scan for lung cancer screening. Lung Cancer. 2014;84(3):307-9. https://doi.org/10.1016/j.lungcan.2014.03.003.
Monu J, Triplette M, Wood DE, et al. Evaluating knowledge, attitudes, and beliefs about lung cancer screening using crowdsourcing. Chest. 2020;158(1):386-92. https://doi.org/10.1016/j.chest.2019.12.048.
Tseng TS, Gross T, Celestin MD, et al. Knowledge and attitudes towards low dose computed tomography lung cancer screening and smoking among African Americans - a mixed method study. Transl Cancer Res. 2019;8(S4):S431-42. https://doi.org/10.21037/tcr.2019.04.18.
Park J, Lee J, Kim Y. Public opinion on implementing the National Lung Cancer Screening Program in Korea. Transl Lung Cancer Res. 2021;10(3):1355-67. https://doi.org/10.21037/tlcr-20-865.
Междисциплинарный центр исследований общественного здоровья. Первый национальный отчёт «Мониторинг общественного здоровья» [Интернет]. [Centre for Public Health Studies. Russian National Health Telephone Survey (RNHTS) [Internet] (In Russ.)]. 2022. [cited 2023 Jul 8]. Available from: https://monitoring.sechenov.ru/
Это произведение доступно по лицензии Creative Commons «Attribution-NonCommercial-NoDerivatives» («Атрибуция — Некоммерческое использование — Без производных произведений») 4.0 Всемирная.
© АННМО «Вопросы онкологии», Copyright (c) 2023